Views | |
---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 52 |
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 0 | 6 | 1 | 1 | 7 | 0 | 1 |
Views | |
---|---|
2019_Ertaş_etal.pdf | 111 |
2019_Ertaş_etal.pdf | 6 |